1. Home
  2. MTZ vs BIO Comparison

MTZ vs BIO Comparison

Compare MTZ & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$266.69

Market Cap

21.1B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$382.79

Market Cap

8.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTZ
BIO
Founded
1929
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
8.0B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
MTZ
BIO
Price
$266.69
$382.79
Analyst Decision
Strong Buy
Buy
Analyst Count
18
4
Target Price
$339.47
$339.75
AVG Volume (30 Days)
1.6M
278.6K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
146.12
142.61
EPS
2.42
N/A
Revenue
$14,299,171,000.00
$2,583,200,000.00
Revenue This Year
$20.38
$2.74
Revenue Next Year
$10.18
$3.20
P/E Ratio
$111.57
N/A
Revenue Growth
16.22
0.65
52 Week Low
$171.05
$236.73
52 Week High
$441.43
$380.71

Technical Indicators

Market Signals
Indicator
MTZ
BIO
Relative Strength Index (RSI) 38.44 78.33
Support Level $252.45 $289.16
Resistance Level $310.36 N/A
Average True Range (ATR) 13.73 12.16
MACD 2.15 1.66
Stochastic Oscillator 20.76 93.14

Price Performance

Historical Comparison
MTZ
BIO

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: